Lista de obras -

Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 Diabetes

artículo científico publicado en 2015

Angiogenic Abnormalities in Diabetes Mellitus: Mechanistic and Clinical Aspects

artículo científico publicado en 2019

Circulating Stem Cells Associate With Adiposity and Future Metabolic Deterioration in Healthy Subjects

artículo científico publicado en 2015

Circulating stem cells and cardiovascular outcomes: from basic science to the clinic

artículo científico publicado en 2019

DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes.

artículo científico publicado en 2017

Diabetes mellitus impairs circulating proangiogenic granulocytes

artículo científico publicado en 2020

Diabetes pharmacotherapy and circulating stem/progenitor cells. State of the art and evidence gaps

artículo científico publicado en 2020

Dipeptidyl peptidase-4 inhibitors moderate the risk of genitourinary tract infections associated with sodium-glucose co-transporter-2 inhibitors.

artículo científico publicado en 2017

Dosimetric effects of residual uncertainties in carbon ion treatment of head chordoma

artículo científico publicado en 2014

Effects of Age, Diabetes, and Vascular Disease on Growth Differentiation Factor 11: First-in-Human Study

artículo científico publicado en 2015

Effects of SGLT2 Inhibitors on Circulating Stem and Progenitor Cells in Patients With Type 2 Diabetes

artículo científico publicado en 2018

Effects of glucose variability on hematopoietic stem/progenitor cells in patients with type 1 diabetes

scientific article published on 04 May 2020

Effects of hypoglycaemia on circulating stem and progenitor cells in diabetic patients

artículo científico publicado en 2017

Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial

artículo científico publicado en 2017

Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial

scientific article published on 14 August 2019

Euglycemic Ketoacidosis

artículo científico publicado en 2020

Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study

artículo científico publicado en 2020

Exposure to DPP-4 inhibitors and risk of pneumonia among people with type 2 diabetes. Retrospective cohort study and meta-analysis

artículo científico publicado en 2020

Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence

scientific article published on 21 January 2020

Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy

scientific article published on 11 May 2020

Hematopoietic and Nonhematopoietic p66Shc Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in Diabetes

Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19

scientific article published on 16 September 2020

Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients

artículo científico publicado en 2013

Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes

artículo científico publicado en 2016

Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy

artículo científico publicado en 2020

NETosis is induced by high glucose and associated with type 2 diabetes.

artículo científico publicado en 2014

Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration

scientific article published on 14 August 2020

Radiotherapy in Prostate Cancer Patients With Pelvic Lymphocele After Surgery: Clinical and Dosimetric Data of 30 Patients

artículo científico publicado en 2014

Response to "Urinary obstruction in prostate cancer patients from the Dutch trial (68 Gy vs. 78 Gy): relationships with local dose, acute effects, and baseline characteristics" (Int J Radiat Oncol Biol Phys 2010;78:19-25)

artículo científico publicado en 2011

SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System

artículo científico publicado en 2017

Shift of monocyte subsets along their continuum predicts cardiovascular outcomes.

artículo científico publicado en 2017

Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literature.

artículo científico publicado en 2017

Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double-blind, placebo-controlled trial

artículo científico publicado en 2020

Subclinical Hypothyroidism and Metabolic Syndrome: A Common Association by Chance or a Cardiovascular Risk Driver?

artículo científico publicado en 2016

Synergistic interactions among metabolic syndrome components and homeostasis model assessment of insulin resistance in a middle-aged general population over time

artículo científico publicado en 2015

Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus

artículo científico publicado en 2019

The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care. Analysis from an outbreak area in North-East Italy

artículo científico publicado en 2020

The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo

artículo científico publicado en 2018

[11C]choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy.

artículo científico publicado en 2013

p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complications

artículo científico publicado en 2018

Lista de obras de

Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 Diabetes

Angiogenic Abnormalities in Diabetes Mellitus: Mechanistic and Clinical Aspects

Circulating Stem Cells Associate With Adiposity and Future Metabolic Deterioration in Healthy Subjects

Circulating stem cells and cardiovascular outcomes: from basic science to the clinic

DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes.

Diabetes mellitus impairs circulating proangiogenic granulocytes

Diabetes pharmacotherapy and circulating stem/progenitor cells. State of the art and evidence gaps

Dipeptidyl peptidase-4 inhibitors moderate the risk of genitourinary tract infections associated with sodium-glucose co-transporter-2 inhibitors.

Dosimetric effects of residual uncertainties in carbon ion treatment of head chordoma

Effects of Age, Diabetes, and Vascular Disease on Growth Differentiation Factor 11: First-in-Human Study

Effects of SGLT2 Inhibitors on Circulating Stem and Progenitor Cells in Patients With Type 2 Diabetes

Effects of glucose variability on hematopoietic stem/progenitor cells in patients with type 1 diabetes

Effects of hypoglycaemia on circulating stem and progenitor cells in diabetic patients

Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial

Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial

Euglycemic Ketoacidosis

Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study

Exposure to DPP-4 inhibitors and risk of pneumonia among people with type 2 diabetes. Retrospective cohort study and meta-analysis

Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence

Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy

Hematopoietic and Nonhematopoietic p66Shc Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in Diabetes

Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19

Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients

Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes

Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy

NETosis is induced by high glucose and associated with type 2 diabetes.

Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration

Radiotherapy in Prostate Cancer Patients With Pelvic Lymphocele After Surgery: Clinical and Dosimetric Data of 30 Patients

Response to "Urinary obstruction in prostate cancer patients from the Dutch trial (68 Gy vs. 78 Gy): relationships with local dose, acute effects, and baseline characteristics" (Int J Radiat Oncol Biol Phys 2010;78:19-25)

SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System

Shift of monocyte subsets along their continuum predicts cardiovascular outcomes.

Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literature.

Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double-blind, placebo-controlled trial

Subclinical Hypothyroidism and Metabolic Syndrome: A Common Association by Chance or a Cardiovascular Risk Driver?

Synergistic interactions among metabolic syndrome components and homeostasis model assessment of insulin resistance in a middle-aged general population over time

Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus

The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care. Analysis from an outbreak area in North-East Italy

The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo

[11C]choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy.

p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complications